Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19
Scientists at Oxford-based pharmatech company Exscientia are hoping to find a drug against COVID-19 within a year, using artificial intelligence technology.
In mid-March, they received a set of 12,000 de-risked drugs (drug molecules and molecules that have been checked for human safety) from the Calibr Institute based in California.
The lab has selected four different viral targets, which are proteins from the SARS-CoV-2 and are checking if they are affecting the molecules.
Scientific coordinator Aude Echalier says that it is essential to consider the "small molecule drug route" as a vaccine may never be found.
(Source: AFP)
Children risk 'generational catastrophe' from COVID: Watchdog
WHO in ‘imminent danger’ due to funding shortage: Top expert
‘New strain of coronavirus may have leaked from UK vaccine lab’
IRGC: Israel’s Dimnoa nuclear reactor not among Op. True Promise’s targets
'Stop any further Israeli adventurism,' Iran FM tells Security Council
Google fires 28 employees for protesting military deal with Israel
Burkina Faso expels three French diplomats over ‘subversive activities’
Iran slams G7 statement, vows no iota of doubt to respond to aggression
German authorities arrest Jewish activist over pro-Palestinian demos
Far-right Israeli minister calls for execution of Palestinian prisoners
VIDEO | Time to halt military operations in besieged Gaza: Italy
This makes it easy to access the Press TV website
